NGO for UN life sciences technology evaluation body
By Gireesh Chandra Prasad,
Express Pharma Pulse
| 01. 24. 2004
NGO for UN life sciences technology evaluation body
Gireesh Chandra Prasad
Express Pharma Pulse
January 22, 2004
Canada-based NGO "etc group", which addresses international governance issues and corporate power at global and regional levels, will propose creation of a United Nations body to evaluate the emerging medical, biotech and pharmaceutical technologies so that 'socially irresponsible technologies' like inheritable genetic modification do not enter the market.
etc group executive director Pat Roy Mooney told Express Pharma Pulse on the sidelines of the ongoing World Social Forum conference here on January 18 that the organisation will submit a national draft in April to the UN, the WHO and the International Labour Organisation (ILO) which will also recommend a commission under the UN to monitor technology distribution, access, benefit sharing and archiving endangered technologies. He said the body would monitor the development of technologies from initial stages so that the research progresses in the right direction. There would also be an exit strategy if it the project is not feasible.
Earlier, addressing a conference on plant and human genetic technologies, Oakland-based Centre for...
Related Articles
What We Inherit by Sam Trejo and Daphne O. Martschenko; and Original Sin by Kathryn Paige Harden have a great deal in common, with substantial differences in style and emphasis. Both books attempt, in different ways, to show the reader just where current research into human genomics stands, where that might be going, and why the authors are interested. In short, the influence of genomic research on our societies is already large and seems likely to change them in ways...
By Dan Falk, Nautilus | 08.20.2026
The pseudoscience of eugenics, founded on the mistaken notion that nature envisions some “right” combination of genes, and that selective breeding can improve the human race, is making a comeback. While the heyday of eugenics was a century ago, the...
By Emily Packard Dawson and Lainie Friedman Ross, MedPage Today | 08.18.2026
Few things evoke a greater sense of desperation than a parent seeking an experimental treatment for their child. That desperation can make even extraordinary risks seem worth taking. This dynamic has come into stark relief after Mei, a 6-year-old girl...
By Ryan Cross, Endpoints News | 08.20.2026
China’s cheap, fast and quiet system for testing cutting-edge medicines is facing scrutiny after the deaths of three people in investigator-initiated trials.
The studies, also known as IITs, allow experimental cell and gene therapies to be tested without oversight from...
